Davide Campari Milano NV
MIL:CPR

Watchlist Manager
Davide Campari Milano NV Logo
Davide Campari Milano NV
MIL:CPR
Watchlist
Price: 5.644 EUR 2.17% Market Closed
Market Cap: 6.8B EUR
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

0
Operating Cash Flow
+0%
Growth Rates:
1 Year
+328%
3 Years
+39%
5 Years
+85%
7 Years
+115%
10 Years
+137%
0
Investing Cash Flow
+0%
Growth Rates:
1 Year
-470%
3 Years
-946%
5 Years
-
7 Years
-
10 Years
-606%
0
Financing Cash Flow
+0%
Growth Rates:
1 Year
+204%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Cash Flow Statement
Davide Campari Milano NV

Rotate your device to view
Cash Flow Statement
Currency: EUR
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Dec-2004 Jun-2005 Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024
Operating Cash Flow
Net Income
97
105
118
120
191
226
201
202
195
200
236
253
270
292
296
302
288
264
289
290
255
275
310
300
319
346
394
416
381
372
386
318
232
346
401
473
512
566
540
532
392
Depreciation & Amortization
18
18
17
18
19
20
20
19
19
20
25
27
26
28
30
31
33
37
40
38
39
44
47
50
53
56
57
56
54
61
72
76
78
77
80
83
91
100
110
118
128
Change in Deffered Taxes
11
15
19
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Items
(3)
(5)
(8)
(7)
(7)
(8)
(1)
(9)
(11)
(10)
8
20
8
2
(7)
(5)
8
17
(3)
(8)
43
17
11
39
40
2
(41)
(43)
(31)
(8)
(20)
14
39
54
77
2
4
66
63
40
158
Cash Taxes Paid
0
0
0
0
37
43
40
62
38
18
43
68
50
60
68
78
88
76
76
57
53
55
54
50
47
50
41
43
49
33
45
116
120
68
79
141
141
172
195
94
85
Cash Interest Paid
0
0
0
0
0
14
0
13
25
28
39
41
44
44
46
47
58
51
62
62
63
63
62
61
103
95
35
36
30
33
31
33
30
32
23
22
26
43
64
86
94
Change in Working Capital
(8)
(17)
(49)
(57)
(75)
(67)
(49)
(73)
(32)
97
2
(121)
(73)
(102)
(116)
(143)
(104)
(77)
(105)
(106)
(54)
(36)
(63)
51
(17)
(114)
(100)
(111)
(74)
(119)
(75)
(122)
(76)
(68)
(74)
(146)
(225)
(519)
(557)
(275)
(7)
Cash from Operating Activities
115
N/A
116
+1%
97
-16%
90
-7%
128
+42%
167
+30%
170
+2%
140
-18%
172
+23%
307
+79%
271
-12%
180
-34%
231
+28%
221
-4%
203
-8%
185
-9%
224
+21%
242
+8%
221
-9%
215
-3%
283
+32%
300
+6%
305
+2%
439
+44%
395
-10%
289
-27%
311
+8%
319
+3%
330
+3%
306
-7%
363
+19%
286
-21%
272
-5%
409
+50%
484
+18%
412
-15%
380
-8%
214
-44%
157
-27%
415
+165%
671
+62%
Investing Cash Flow
Capital Expenditures
(30)
(19)
(19)
(18)
(68)
(71)
(34)
(42)
(48)
(60)
(63)
(67)
(66)
(47)
(40)
(41)
(55)
(74)
(65)
(45)
(56)
(59)
(54)
(53)
(64)
(75)
(86)
(78)
(83)
(86)
(92)
(94)
(85)
(137)
(146)
(133)
(355)
(382)
(315)
(448)
(460)
Other Items
(4)
(132)
(125)
(123)
(112)
27
(13)
(66)
(50)
(432)
(581)
(151)
27
18
(7)
(2)
(315)
(294)
(6)
(192)
(171)
23
(1)
(403)
(311)
26
181
240
6
(10)
96
(9)
(168)
(65)
(7)
(130)
(451)
(323)
34
(1 042)
(1 142)
Cash from Investing Activities
(34)
N/A
(152)
-346%
(144)
+5%
(141)
+2%
(180)
-27%
(44)
+76%
(47)
-6%
(108)
-133%
(98)
+9%
(491)
-400%
(644)
-31%
(217)
+66%
(39)
+82%
(29)
+25%
(47)
-60%
(43)
+9%
(370)
-770%
(368)
+0%
(71)
+81%
(237)
-235%
(227)
+4%
(36)
+84%
(55)
-52%
(456)
-730%
(375)
+18%
(49)
+87%
95
N/A
163
+72%
(77)
N/A
(96)
-25%
4
N/A
(103)
N/A
(252)
-144%
(201)
+20%
(153)
+24%
(263)
-72%
(806)
-206%
(705)
+12%
(281)
+60%
(1 490)
-430%
(1 602)
-8%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
33
41
2
0
(5)
(6)
(6)
(7)
2
(12)
(21)
(9)
(12)
(53)
(26)
18
(7)
(56)
(29)
15
(8)
(14)
(54)
(60)
(56)
(45)
(47)
(136)
(271)
(155)
(3)
(93)
(121)
(26)
34
654
642
Net Issuance of Debt
51
64
75
255
90
(247)
(103)
(36)
(30)
314
413
92
11
4
96
86
281
290
1
16
(151)
(152)
503
401
(364)
(263)
(66)
(72)
(11)
140
(114)
92
212
(69)
(25)
(174)
255
743
432
549
591
Cash Paid for Dividends
(25)
(28)
(28)
(28)
(28)
(29)
(29)
(32)
(32)
(32)
(32)
(35)
(35)
(35)
(35)
(41)
(41)
(40)
(40)
(46)
(46)
(46)
(46)
(52)
(52)
(52)
(52)
(58)
(58)
(57)
(57)
(63)
(63)
(62)
(62)
(68)
(68)
(68)
(68)
(78)
(78)
Other
2
33
8
(20)
(53)
(65)
(25)
(25)
(27)
(35)
(40)
(36)
(45)
(46)
(46)
(47)
(54)
(62)
(72)
(68)
(79)
(26)
(61)
(105)
(114)
(104)
(39)
(42)
(36)
(41)
(54)
(46)
(18)
(29)
(26)
(28)
(29)
(28)
(75)
(108)
(173)
Cash from Financing Activities
28
N/A
69
+142%
55
-20%
207
+278%
42
-80%
(300)
N/A
(156)
+48%
(99)
+37%
(94)
+5%
242
N/A
336
+38%
15
-95%
(66)
N/A
(89)
-34%
(6)
+93%
(11)
-74%
174
N/A
136
-22%
(136)
N/A
(81)
+41%
(283)
-251%
(279)
+1%
368
N/A
259
-30%
(538)
N/A
(433)
+20%
(211)
+51%
(232)
-10%
(160)
+31%
(3)
+98%
(273)
-7 935%
(153)
+44%
(140)
+8%
(314)
-125%
(116)
+63%
(363)
-214%
38
N/A
621
+1 526%
323
-48%
1 016
+215%
982
-3%
Change in Cash
Effect of Foreign Exchange Rates
(3)
(8)
(3)
5
5
5
(7)
(10)
(6)
(22)
(6)
18
5
(7)
5
11
0
0
(12)
0
16
0
(5)
(4)
27
10
(35)
(17)
6
4
(4)
(12)
(36)
(13)
28
79
32
(39)
(13)
(9)
(4)
Net Change in Cash
106
N/A
25
-76%
6
-78%
161
+2 822%
(6)
N/A
(172)
-2 720%
(39)
+77%
(77)
-97%
(27)
+64%
36
N/A
(43)
N/A
(4)
+90%
130
N/A
96
-26%
155
+61%
142
-8%
28
-80%
10
-66%
2
-81%
(102)
N/A
(211)
-106%
(16)
+93%
614
N/A
238
-61%
(490)
N/A
(183)
+63%
160
N/A
233
+46%
100
-57%
211
+112%
91
-57%
18
-80%
(156)
N/A
(119)
+24%
243
N/A
(135)
N/A
(356)
-163%
91
N/A
185
+104%
(68)
N/A
46
N/A
Free Cash Flow
Free Cash Flow
85
N/A
97
+14%
78
-19%
72
-8%
60
-17%
96
+59%
136
+43%
98
-28%
123
+26%
247
+100%
208
-16%
114
-46%
165
+45%
174
+5%
162
-7%
144
-11%
169
+17%
167
-1%
156
-7%
170
+9%
228
+34%
240
+6%
251
+4%
387
+54%
332
-14%
214
-35%
225
+5%
242
+7%
247
+2%
220
-11%
271
+23%
192
-29%
187
-2%
273
+46%
338
+24%
279
-18%
25
-91%
(169)
N/A
(159)
+6%
(34)
+79%
210
N/A

See Also

Summary
CPR intrinsic value, competitors valuation, and company profile.
DCF Valuation
CPR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CPR stock valuation using valuation multiples.
Wall Street Estimates
CPR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CPR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 242,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.